# Lennart Hammarström

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lennart-hammarstrom/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,934 |
| Field | Immunodeficiency and Autoimmune Disorders |
| h-index | 100 |
| i10-index | 502 |
| Last Known Institution | Karolinska Institutet |
| OpenAlex ID | https://openalex.org/A5008915149 |
| ORCID iD | https://orcid.org/0000-0002-8635-9609 |
| Works | 748 |

## Researcher papers

- [International Consensus Document (ICON): Common Variable Immunodeficiency Disorders](https://scholariq.org/papers/international-consensus-document-icon-common-variable-immunodeficiency-disorders/)
- [Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans](https://scholariq.org/papers/mutations-in-tnfrsf13b-encoding-taci-are-associated-with-common-variable/)
- [Clinical spectrum of X-linked hyper-IgM syndrome](https://scholariq.org/papers/clinical-spectrum-of-x-linked-hyper-igm-syndrome/)
- [Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths](https://scholariq.org/papers/autoantibodies-neutralizing-type-i-ifns-are-present-in-4-of-uninfected/)
- [Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study](https://scholariq.org/papers/cancer-risk-among-patients-with-iga-deficiency-or-common-variable/)
- [Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases](https://scholariq.org/papers/mapping-of-multiple-susceptibility-variants-within-the-mhc-region-for-7-immune/)
- [Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection](https://scholariq.org/papers/persistence-of-sars-cov-2-specific-b-and-t-cell-responses-in-convalescent-covid/)
- [Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score](https://scholariq.org/papers/long-term-outcome-of-lrba-deficiency-in-76-patients-after-various-treatment/)
- [Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations](https://scholariq.org/papers/characterization-of-the-clinical-and-immunologic-phenotype-and-management-of-157/)

## Researcher topics

- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)

## Researcher university

- [Karolinska Institutet](https://scholariq.org/institutions/karolinska-institutet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.